The Effect of Intravenous Immunoglobulin on Jaundice

Phase 3

• Conditions: Jaundice of neonates.; Neonatal jaundice due to other specified excessive hemolysis; P58.8

• Registration Number: IRCT20171218037936N3
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

Neonates with Jaundice
Informed consent of parents

Exclusion Criteria

Neonates weighing less than 2500 grams

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: Once on the time of discharge. Method of measurement: The length of time that the neonate is hospitalized.;Duration of phototherapy. Timepoint: Once on the time of discharge. Method of measurement: Using a phototherapy machine.;Plasmapheresis. Timepoint: Once on the time of discharge. Method of measurement: Based on file information.;Bilirubin. Timepoint: Measured 4 times every 12 hours. Method of measurement: Blood sampling.;Hemoglobin. Timepoint: Measured 4 times every 12 hours. Method of measurement: Blood sampling.